{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,27]],"date-time":"2025-12-27T21:15:23Z","timestamp":1766870123190,"version":"3.40.3"},"reference-count":80,"publisher":"Bentham Science Publishers Ltd.","issue":"10","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CMC"],"published-print":{"date-parts":[[2025,2]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p>Neopterin (NEO) is an inflammatory biomarker with proposed\ndiagnostic value in cardiovascular diseases. Some correlations have been discovered between\nNEO levels and the incidence, severity, and adverse outcomes of heart failure (HF).\nHowever, there are discrepancies in the results reported in the literature.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p>We conducted a systematic review and meta-analysis of studies comparing urinary\nand blood NEO concentrations between individuals with HF, cardiac insufficiency,\nor dilated cardiomyopathy (DCM) with control groups or those monitoring the role of\nNEO concentrations as a predictive marker of adverse outcomes in HF patients.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>A total of 24 studies that met the inclusion criteria were reviewed. The studies\ndemonstrated the alteration of NEO in blood or urine samples in subjects with HF, cardiac\ninsufficiency, or DCM compared with control groups. Also, reviewing the studies suggested\na link between reduced ejection fraction, higher NYHA classes, and a higher risk\nof adverse cardiac outcomes with increased NEO levels. The meta-analysis of three studies\nrevealed a significant increase in serum NEO levels in HF cases compared to that in\nhealthy controls with an effect size of 3.72 (95 % CI 0.16 to 7.28; p = 0.04).<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>Meta-analysis demonstrated a significant difference between serum NEO\nlevels of HF cases and healthy subjects. This evidence implies the potential of serum NEO\nas a valuable diagnostic biomarker in HF patients. Also, the review of the studies revealed\nthe prognostic potential of NEO. Further research is required to assess the usefulness of\nNEO as a diagnostic\/prognostic biomarker for HF.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/0109298673258661231003045907","type":"journal-article","created":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T04:02:48Z","timestamp":1697169768000},"page":"2021-2039","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Neopterin as a Potential Biomarker for the Early Diagnosis of Heart Failure: A Systematic Review and Meta-analysis"],"prefix":"10.2174","volume":"32","author":[{"given":"Golnaz","family":"Mahmoudvand","sequence":"first","affiliation":[{"name":"Universal Scientific Education and Research Network (USERN) Office, Lorestan University of Medical\nSciences, Khorramabad, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arian Karimi","family":"Rouzbahani","sequence":"additional","affiliation":[{"name":"Universal Scientific Education and Research Network (USERN) Office, Lorestan University of Medical\nSciences, Khorramabad, Iran"},{"name":"Student Research Committee, Lorestan University of Medical Sciences,\nKhorramabad, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"Kheirandish","sequence":"additional","affiliation":[{"name":"Student Research Committee, Faculty of Pharmacy, Mazandaran University of Medical\nSciences, Sari, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amene","family":"Saghazadeh","sequence":"additional","affiliation":[{"name":"Research Center for Immunodeficiencies, Children\u2019s Medical Center, Tehran University\nof Medical Sciences, Tehran, Iran"},{"name":"Systematic Review and Meta-analysis Expert Group (SRMEG), Universal\nScientific Education and Research Network (USERN), Tehran, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nima","family":"Rezaei","sequence":"additional","affiliation":[{"name":"Research Center for Immunodeficiencies, Children\u2019s Medical Center, Tehran University\nof Medical Sciences, Tehran, Iran"},{"name":"Department of Immunology, School of\nMedicine, Tehran University of Medical Sciences, Tehran, Iran"},{"name":"Network of Immunity in Infection,\nMalignancy and Autoimmunity (NIIMA), Universal Scientific Education and Research Network (USERN),\nTehran, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1007\/s10787-022-01028-5","volume":"30","author":"Dogheim G.M.","year":"2022","unstructured":"Dogheim G.M.; Amralla M.T.; Werida R.H.; Role of neopterin as an inflammatory biomarker in congestive heart failure with insights on effect of drug therapies on its level. Inflammopharmacology  2022,30(5),1617-1622","journal-title":"Inflammopharmacology"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1002\/ejhf.2143","volume":"23","author":"Seferovi\u0107 P.M.","year":"2021","unstructured":"Seferovi\u0107 P.M.; Vardas P.; Jankowska E.A.; Maggioni A.P.; Timmis A.; Milinkovi\u0107 I.; Polovina M.; Gale C.P.; Lund L.H.; Lopatin Y.; Lainscak M.; Savarese G.; Huculeci R.; Kazakiewicz D.; Coats A.J.S.; The heart failure association atlas: Heart failure epidemiology and management statistics 2019. Eur J Heart Fail  2021,23(6),906-914","journal-title":"Eur J Heart Fail"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1016\/S0140-6736(18)31808-7","volume":"393","author":"Rossignol P.","year":"2019","unstructured":"Rossignol P.; Hernandez A.F.; Solomon S.D.; Zannad F.; Heart failure drug treatment. Lancet  2019,393(10175),1034-1044","journal-title":"Lancet"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1038\/s41569-020-0379-7","volume":"17","author":"Boorsma E.M.","year":"2020","unstructured":"Boorsma E.M.; ter Maaten J.M.; Damman K.; Dinh W.; Gustafsson F.; Goldsmith S.; Burkhoff D.; Zannad F.; Udelson J.E.; Voors A.A.; Congestion in heart failure: A contemporary look at physiology, diagnosis and treatment. Nat Rev Cardiol  2020,17(10),641-655","journal-title":"Nat Rev Cardiol"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"2121","DOI":"10.1021\/acs.jproteome.9b00002","volume":"18","author":"Li R.","year":"2019","unstructured":"Li R.; He H.; Fang S.; Hua Y.; Yang X.; Yuan Y.; Liang S.; Liu P.; Tian Y.; Xu F.; Zhang Z.; Huang Y.; Time series characteristics of serum branched-chain amino acids for early diagnosis of chronic heart failure. J Proteome Res  2019,18(5),2121-2128","journal-title":"J Proteome Res"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"212910","DOI":"10.1155\/2015\/212910","volume":"2015","author":"Hou Y.","year":"2015","unstructured":"Hou Y.; Adrian-Segarra J.M.; Richter M.; Kubin N.; Shin J.; Werner I.; Walther T.; Sch\u00f6nburg M.; P\u00f6ling J.; Warnecke H.; Animal models and \u201cOmics\u201d technologies for identification of novel biomarkers and drug targets to prevent heart failure. BioMed Res Int  2015,2015,212910","journal-title":"BioMed Res Int"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1002\/ejhf.1749","volume":"22","author":"St\u00f6hr R.","year":"2020","unstructured":"St\u00f6hr R.; Brandenburg V.M.; Heine G.H.; Maeder M.T.; Leibundgut G.; Schuh A.; Jeker U.; Pfisterer M.; Sanders-van Wijk S.; Brunner-la Rocca H.P.; Limited role for fibroblast growth factor 23 in assessing prognosis in heart failure patients: data from the TIME-CHF trial. Eur J Heart Fail  2020,22(4),701-709","journal-title":"Eur J Heart Fail"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1007\/s10741-019-09807-z","volume":"24","author":"Sarhene M.","year":"2019","unstructured":"Sarhene M.; Wang Y.; Wei J.; Huang Y.; Li M.; Li L.; Acheampong E.; Zhengcan Z.; Xiaoyan Q.; Yunsheng X.; Jingyuan M.; Xiumei G.; Guanwei F.; Biomarkers in heart failure: The past, current and future. Heart Fail Rev  2019,24(6),867-903","journal-title":"Heart Fail Rev"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.amjcard.2021.11.045","volume":"167","author":"Albar Z.","year":"2022","unstructured":"Albar Z.; Albakri M.; Hajjari J.; Karnib M.; Janus S.E.; Al-Kindi S.G.; Inflammatory markers and risk of heart failure with reduced to preserved ejection fraction. Am J Cardiol  2022,167,68-75","journal-title":"Am J Cardiol"},{"key":"ref=10","first-page":"52","volume":"7","author":"Mohamad M.","year":"2018","unstructured":"Mohamad M.; Ebeid S.; Shawky Khater M.; Alsadany M.; Interferon-gamma-inducible guanosine triphosphate cyclohydrolase 1 (GTP-CH1) pathway is associated with frailty in Egyptian elderly. Rep Biochem Mol Biol  2018,7(1),52-58","journal-title":"Rep Biochem Mol Biol"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/s11886-020-01382-2","volume":"22","author":"Castillo E.C.","year":"2020","unstructured":"Castillo E.C.; V\u00e1zquez-Garza E.; Yee-Trejo D.; Garc\u00eda-Rivas G.; Torre-Amione G.; What is the role of the inflammation in the pathogenesis of heart failure? Curr Cardiol Rep  2020,22(11),139","journal-title":"Curr Cardiol Rep"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1016\/0735-1097(93)90776-W","volume":"22","author":"Wiedermann C.J.","year":"1993","unstructured":"Wiedermann C.J.; Beimpold H.; Herold M.; Knapp E.; Braunsteiner H.; Increased levels of serum neoprotein and decreased production of neutrophil superoxide anions in chronic heart failure with elevated levels of tumor necrosis factor-alpha. J Am Coll Cardiol  1993,22(7),1897-1901","journal-title":"J Am Coll Cardiol"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1080\/00015385.2018.1478266","volume":"74","author":"Demir \u015e.","year":"2019","unstructured":"Demir \u015e.; Ede H.; Kaplan M.; Yavuz F.; Y\u00fccel C.; Kurt \u0130.H.; Neopterin as a novel marker; well correlated with mortality and morbidity in patients with advanced systolic heart failure. Acta Cardiol  2019,74(3),216-221","journal-title":"Acta Cardiol"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","volume":"372","author":"Page M.J.","year":"2021","unstructured":"Page M.J.; McKenzie J.E.; Bossuyt P.M.; Boutron I.; Hoffmann T.C.; Mulrow C.D.; Shamseer L.; Tetzlaff J.M.; Akl E.A.; Brennan S.E.; Chou R.; Glanville J.; Grimshaw J.M.; Hr\u00f3bjartsson A.; Lalu M.M.; Li T.; Loder E.W.; Mayo-Wilson E.; McDonald S.; McGuinness L.A.; Stewart L.A.; Thomas J.; Tricco A.C.; Welch V.A.; Whiting P.; Moher D.; The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. BMJ  2021,372(71),n71","journal-title":"BMJ"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/1471-2288-14-135","volume":"14","author":"Wan X.","year":"2014","unstructured":"Wan X.; Wang W.; Liu J.; Tong T.; Estimating the sample mean and standard deviation from the sample size, median, range and\/or interquartile range. BMC Med Res Methodol  2014,14(1),135","journal-title":"BMC Med Res Methodol"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"l4898","DOI":"10.1136\/bmj.l4898","volume":"366","author":"Sterne J.A.C.","year":"2019","unstructured":"Sterne J.A.C.; Savovi\u0107 J.; Page M.J.; Elbers R.G.; Blencowe N.S.; Boutron I.; Cates C.J.; Cheng H.Y.; Corbett M.S.; Eldridge S.M.; Emberson J.R.; Hern\u00e1n M.A.; Hopewell S.; Hr\u00f3bjartsson A.; Junqueira D.R.; J\u00fcni P.; Kirkham J.J.; Lasserson T.; Li T.; McAleenan A.; Reeves B.C.; Shepperd S.; Shrier I.; Stewart L.A.; Tilling K.; White I.R.; Whiting P.F.; Higgins J.P.T.; RoB 2: A revised tool for assessing risk of bias in randomised trials. BMJ  2019,366,l4898","journal-title":"BMJ"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2014\/281790","volume":"2014","author":"Caruso R.","year":"2014","unstructured":"Caruso R.; Campolo J.; Verde A.; Botta L.; Cozzi L.; Parolini M.; Milazzo F.; Nonini S.; Martinelli L.; Paino R.; Marraccini P.; Frigerio M.; Relationship between early inflammatory response and clinical evolution of the severe multiorgan failure in mechanical circulatory support-treated patients. Mediators Inflamm  2014,2014,1-9","journal-title":"Mediators Inflamm"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1515\/CCLM.2008.213","volume":"46","author":"Djordjevic V.B.","year":"2008","unstructured":"Djordjevic V.B.; Stojanovic I.; Cosic V.; Zvezdanovic L.; Deljanin-Ilic M.; Dimic S.; Kundalic B.; Cvetkovic T.; Jevtovic-Stoimenov T.; Serum neopterin, nitric oxide, inducible nitric oxide synthase and tumor necrosis factor-\u03b1 levels in patients with ischemic heart disease. Clin Chem Lab Med  2008,46(8),1149-1155","journal-title":"Clin Chem Lab Med"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1111\/j.1399-0012.2010.01345.x","volume":"25","author":"Grebe S.O.","year":"2011","unstructured":"Grebe S.O.; Kuhlmann U.; Fogl D.; Luyckx V.A.; Mueller T.F.; Macrophage activation is associated with poorer long-term outcomes in renal transplant patients. Clin Transplant  2011,25(5),744-754","journal-title":"Clin Transplant"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.forsciint.2008.04.021","volume":"179","author":"Ishikawa T.","year":"2008","unstructured":"Ishikawa T.; Hamel M.; Zhu B.L.; Li D.R.; Zhao D.; Michiue T.; Maeda H.; Comparative evaluation of postmortem serum concentrations of neopterin and C-reactive protein. Forensic Sci Int  2008,179(2-3),135-143","journal-title":"Forensic Sci Int"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1097\/00019501-200609000-00003","volume":"17","author":"Johnston D.T.","year":"2006","unstructured":"Johnston D.T.; Gagos M.; Raio N.; Ragolia L.; Shenouda D.; Davis-Lorton M.A.; De Leon J.R.; Alterations in serum neopterin correlate with thrombolysis in myocardial infarction risk scores in acute coronary syndromes. Coron Artery Dis  2006,17(6),511-516","journal-title":"Coron Artery Dis"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.atherosclerosis.2008.01.009","volume":"201","author":"Kaski J.C.","year":"2008","unstructured":"Kaski J.C.; Consuegra-Sanchez L.; Fernandez-Berges D.J.; Cruz-Fernandez J.M.; Garcia-Moll X.; Marrugat J.; Mostaza J.; Toro-Cebada R.; Gonz\u00e1lez-Juanatey J.R.; Guzm\u00e1n-Mart\u00ednez G.; Elevated serum neopterin levels and adverse cardiac events at 6 months follow-up in Mediterranean patients with non-ST-segment elevation acute coronary syndrome. Atherosclerosis  2008,201(1),176-183","journal-title":"Atherosclerosis"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1157\/13045655","volume":"56","author":"Kaski J.C.","year":"2003","unstructured":"Kaski J.C.; Cruz-Fern\u00e1ndez J.M.; Fern\u00e1ndez-Berg\u00e9s D.; Garc\u00eda-Moll X.; Mart\u00edn Jadraque L.; Mostaza J.; L\u00f3pez Garc\u00eda-Aranda V.; Gonz\u00e1lez Juanatey J.R.; Castro Beiras A.; Mart\u00edn Luengo C.; Alonso Garc\u00eda A.; L\u00f3pez-Besc\u00f3s L.; Marcos G\u00f3mez G.; Inflammation markers and risk stratification in patients with acute coronary syndromes: Design of the SIESTA study (Systemic inflammation evaluation in patients with non-ST segment elevation Acute coronary syndromes). Rev Esp Cardiol  2003,56(4),389-395","journal-title":"Rev Esp Cardiol"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"251","DOI":"10.5507\/bp.2014.003","volume":"159","author":"Kluz K.","year":"2015","unstructured":"Kluz K.; Parenica J.; Kubkova L.; Littnerova S.; Tomandl J.; Poloczek M.; Toman O.; Tesak M.; Cermakova Z.; Gottwaldova J.; Manousek J.; Pavkova Goldbergova M.; Spinar J.; Jarkovsky J.; Unstable angina pectoris prior to ST elevation myocardial infarction in patients treated with primary percutaneous coronary intervention has no influence on prognosis. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub  2015,159(2),251-258","journal-title":"Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1152\/physiolgenomics.00033.2019","volume":"51","author":"Kwee L.C.","year":"2019","unstructured":"Kwee L.C.; Neely M.L.; Grass E.; Gregory S.G.; Roe M.T.; Ohman E.M.; Fox K.A.A.; White H.D.; Armstrong P.W.; Bowsman L.M.; Haas J.V.; Duffin K.L.; Chan M.Y.; Shah S.H.; Associations of osteopontin and NT-proBNP with circulating miRNA levels in acute coronary syndrome. Physiol Genomics  2019,51(10),506-515","journal-title":"Physiol Genomics"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"4222","DOI":"10.4238\/2013.October.7.8","volume":"12","author":"Liu Z.Y.","year":"2013","unstructured":"Liu Z.Y.; Li Y.D.; Relationship between serum neopterin levels and coronary heart disease. Genet Mol Res  2013,12(4),4222-4229","journal-title":"Genet Mol Res"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1016\/j.jcin.2010.06.015","volume":"3","author":"Locca D.","year":"2010","unstructured":"Locca D.; Bucciarelli-Ducci C.; Ferrante G.; La Manna A.; Keenan N.G.; Grasso A.; Barlis P.; Del Furia F.; Prasad S.K.; Kaski J.C.; Pennell D.J.; Di Mario C.; New universal definition of myocardial infarction applicable after complex percutaneous coronary interventions? JACC Cardiovasc Interv  2010,3(9),950-958","journal-title":"JACC Cardiovasc Interv"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.intimp.2014.11.013","volume":"24","author":"Lyu Y.","year":"2015","unstructured":"Lyu Y.; Jiang X.; Dai W.; The roles of a novel inflammatory neopterin in subjects with coronary atherosclerotic heart disease. Int Immunopharmacol  2015,24(2),169-172","journal-title":"Int Immunopharmacol"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1007\/s12265-009-9121-x","volume":"2","author":"Miller W.L.","year":"2009","unstructured":"Miller W.L.; Hartman K.A.; Hodge D.O.; Hartman S.; Struck J.; Morgenthaler N.G.; Bergmann A.; Jaffe A.S.; Response of novel biomarkers to BNP infusion in patients with decompensated heart failure: A multimarker paradigm. J Cardiovasc Transl Res  2009,2(4),526-535","journal-title":"J Cardiovasc Transl Res"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1111\/ctr.12285","volume":"28","author":"Pihlstr\u00f8m H.","year":"2014","unstructured":"Pihlstr\u00f8m H.; Mj\u00f8en G.; M\u00e4rz W.; Olav Dahle D.; Abedini S.; Holme I.; Fellstr\u00f6m B.; Jardine A.; Pilz S.; Holdaas H.; Neopterin is associated with cardiovascular events and all-cause mortality in renal transplant patients. Clin Transplant  2014,28(1),111-119","journal-title":"Clin Transplant"},{"key":"ref=31","first-page":"250","volume":"10","author":"Ragab M.","year":"2005","unstructured":"Ragab M.; Hassan H.; Zaytoun T.; Refai W.; Rocks B.; Elsammak M.; Evaluation of serum neopterin, high-sensitivity C-reactive protein and thiobarbituric acid reactive substances in Egyptian patients with acute coronary syndromes. Exp Clin Cardiol  2005,10(4),250-255","journal-title":"Exp Clin Cardiol"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"3071","DOI":"10.1161\/CIRCULATIONAHA.106.666511","volume":"115","author":"Ray K.K.","year":"2007","unstructured":"Ray K.K.; Morrow D.A.; Sabatine M.S.; Shui A.; Rifai N.; Cannon C.P.; Braunwald E.; Long-term prognostic value of neopterin: A novel marker of monocyte activation in patients with acute coronary syndrome. Circulation  2007,115(24),3071-3078","journal-title":"Circulation"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"3024","DOI":"10.1093\/eurheartj\/ehq322","volume":"31","author":"Schnabel R.B.","year":"2010","unstructured":"Schnabel R.B.; Schulz A.; Messow C.M.; Lubos E.; Wild P.S.; Zeller T.; Sinning C.R.; Rupprecht H.J.; Bickel C.; Peetz D.; Cambien F.; Kempf T.; Wollert K.C.; Benjamin E.J.; Lackner K.J.; M\u00fcnzel T.F.; Tiret L.; Vasan R.S.; Blankenberg S.; Multiple marker approach to risk stratification in patients with stable coronary artery disease. Eur Heart J  2010,31(24),3024-3031","journal-title":"Eur Heart J"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/S0735-1097(97)00172-1","volume":"30","author":"Schumacher M.","year":"1997","unstructured":"Schumacher M.; Halwachs G.; Tatzber F.; Fruhwald F.M.; Zweiker R.; Watzinger N.; Eber B.; Wilders-Truschnig M.; Esterbauer H.; Klein W.; Increased neopterin in patients with chronic and acute coronary syndromes. J Am Coll Cardiol  1997,30(3),703-707","journal-title":"J Am Coll Cardiol"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1016\/j.ijcard.2012.12.090","volume":"168","author":"Sulo G.","year":"2013","unstructured":"Sulo G.; Vollset S.E.; Nyg\u00e5rd O.; Midttun \u00d8.; Ueland P.M.; Eussen S.J.P.M.; Pedersen E.R.; Tell G.S.; Neopterin and kynurenine\u2013tryptophan ratio as predictors of coronary events in older adults, the Hordaland Health Study. Int J Cardiol  2013,168(2),1435-1440","journal-title":"Int J Cardiol"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1016\/j.amjcard.2003.07.031","volume":"92","author":"van Haelst P.L.","year":"2003","unstructured":"van Haelst P.L.; Liem A.; van Boven A.J.; Veeger N.J.; van Veldhuisen D.J.; Cohen Tervaert J.W.; Gans R.O.; Zijlstra F.; Usefulness of elevated neopterin and C-reactive protein levels in predicting cardiovascular events in patients with non-Q-wave myocardial infarction. Am J Cardiol  2003,92(10),1201-1203","journal-title":"Am J Cardiol"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1111\/j.1365-2249.2004.02602.x","volume":"138","author":"Van Haelst P.L.","year":"2004","unstructured":"Van Haelst P.L.; Tervaert J.W.C.; Bijzet J.; Balj\u00e9-Volkers C.; May J.F.; Langeveld B.; Gans R.O.B.; Circulating monocytes in patients with acute coronary syndromes lack sufficient interleukin-10 production after lipopolysaccharide stimulation. Clin Exp Immunol  2004,138(2),364-368","journal-title":"Clin Exp Immunol"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"692","DOI":"10.5152\/akd.2011.190","volume":"11","author":"Varol E.","year":"2011","unstructured":"Varol E.; G\u00fclcan M.; Aylak F.; Ozaydin M.; Sut\u00e7u R.; Erdo\u011fan D.; Do\u011fan A.; Increased neopterin levels and its association with angiographic variables in patients with slow coronary flow: An observational study. Anadolu Kardiyol Derg  2011,11(8),692-697","journal-title":"Anadolu Kardiyol Derg"},{"key":"ref=39","first-page":"24","volume":"51","author":"Barbarash O.L.","year":"2011","unstructured":"Barbarash O.L.; Zykov M.V.; Kashtalap V.V.; Osokina A.V.; Berns S.A.; Karetnikova V.N.; Barbarash L.S.; Prognostic value of various markers of inflammation in ST-elevation myocardial infarction. Kardiologiia  2011,51(3),24-30","journal-title":"Kardiologiia"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"47","DOI":"10.15829\/1728-8800-2018-5-47-52","volume":"17","author":"Popov E.A.","year":"2018","unstructured":"Popov E.A.; Polunina E.A.; Voronina L.P.; Polunina O.S.; Belyakova I.S.; Analysis of inflammatory marker levels in patients with chronic heart failure. Cardiovasc Ther Prev  2018,17(5),47-52","journal-title":"Cardiovasc Ther Prev"},{"key":"ref=41","first-page":"9","volume":"46","author":"Shevchenko A.O.","year":"2006","unstructured":"Shevchenko A.O.; Shevchenko O.P.; Orlova O.V.; Tulikov M.V.; Neoangiogenesis and coronary atherosclerosis: Diagnostic value of a novel biochemical marker placenta growth factor in patients with ischemic heart disease. Kardiologiia  2006,46(11),9-15","journal-title":"Kardiologiia"},{"key":"ref=42","first-page":"256","volume":"28","author":"Wetlicka I.","year":"2010","unstructured":"Wetlicka I.; Korzeniowska K.; Bogda\u0144ski P.; Ka\u017amierczak M.; Chmara E.; Musialik K.; Jab\u0142ecka A.; The assessment of neopterin concentration in patients with heart failure. Pol Merkuriusz Lek  2010,28(166),256-259","journal-title":"Pol Merkuriusz Lek"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"134","DOI":"10.3109\/1354750X.2011.643486","volume":"17","author":"Dominguez-Rodriguez A.","year":"2012","unstructured":"Dominguez-Rodriguez A.; Abreu-Gonzalez P.; Juarez-Prera R.A.; Arroyo-Ucar E.; Hernandez-Garcia C.; Tome M.C.P.; Blanco-Palacios G.E.; Kaski J.C.; Usefulness of serum neopterin levels in acute decompensated heart failure to predict renal dysfunction. Biomarkers  2012,17(2),134-139","journal-title":"Biomarkers"},{"key":"ref=44","first-page":"315","volume":"82","author":"Kalman J.","year":"1990","unstructured":"Kalman J.; Levine B.; Mayer L.; Penn J.; Kukin M.L.; Packer M.; Prognostic importance of circulating neopterin in heart-failure - evidence for monocyte activation in patients with cardiac cachexia. Circulation  1990,82(4),315-315","journal-title":"Circulation"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1515\/cclm.2011.829","volume":"50","author":"Montagnana M.","year":"2012","unstructured":"Montagnana M.; Lippi G.; Danese E.; Salvagno G.L.; Cervellin G.; Guidi G.C.; Serum concentration of neopterin on admission does not improve the diagnostic performance of highly-sensitive troponin I. Clin Chem Lab Med  2012,50(4),747-748","journal-title":"Clin Chem Lab Med"},{"key":"ref=46","doi-asserted-by":"crossref","first-page":"S825","DOI":"10.1161\/CIRCULATIONAHA.109.863431","volume":"120","author":"Sasaki T.","year":"2009","unstructured":"Sasaki T.; Shishido T.; Takahashi H.; Arimoto T.; Miyashita T.; Miyamoto T.; Nitobe J.; Watanabe T.; Takeishi Y.; Kubota I.; High serum level of neopterin predicts cardiac events in chronic heart failure patients with preserved left ventricular systolic function. Circulation  2009,120(18),S825-S825","journal-title":"Circulation"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.ijcard.2009.11.042","volume":"145","author":"Sasaki T.","year":"2010","unstructured":"Sasaki T.; Takeishi Y.; Suzuki S.; Niizeki T.; Kitahara T.; Katoh S.; Ishino M.; Shishido T.; Watanabe T.; Kubota I.; High serum level of neopterin is a risk factor of patients with heart failure. Int J Cardiol  2010,145(2),318","journal-title":"Int J Cardiol"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1002\/ehf2.12070","volume":"3","author":"Yamamoto E.","year":"2016","unstructured":"Yamamoto E.; Hirata Y.; Tokitsu T.; Kusaka H.; Tabata N.; Tsujita K.; Yamamuro M.; Kaikita K.; Watanabe H.; Hokimoto S.; Maruyama T.; Ogawa H.; The clinical significance of plasma neopterin in heart failure with preserved left ventricular ejection fraction. ESC Heart Fail  2016,3(1),53-59","journal-title":"ESC Heart Fail"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"S28","DOI":"10.1016\/j.cardfail.2011.06.095","volume":"17","author":"Shao Z.","year":"2011","unstructured":"Shao Z.; Zhang R.; Borowski A.G.; Thakur A.; Tang W.H.W.; Elevated urinary neopterin levels are associated with cardiac and functional impairment in patients with chronic systolic heart failure. J Card Fail  2011,17(8),S28-S28","journal-title":"J Card Fail"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1161\/01.CIR.97.12.1136","volume":"97","author":"Aukrust P.","year":"1998","unstructured":"Aukrust P.; Ueland T.; M\u00fcller F.; Andreassen A.K.; Nord\u00f8y I.; Aas H.; Kjekshus J.; Simonsen S.; Fr\u00f8land S.S.; Gullestad L.; Elevated circulating levels of C-C chemokines in patients with congestive heart failure. Circulation  1998,97(12),1136-1143","journal-title":"Circulation"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/S0167-5273(97)00332-X","volume":"63","author":"Vonhof S.","year":"1998","unstructured":"Vonhof S.; Brost B.; Stille-Siegener M.; Grumbach I.M.; Kreuzer H.; Figulla H.R.; Monocyte activation in congestive heart failure due to coronary artery disease and idiopathic dilated cardiomyopathy. Int J Cardiol  1998,63(3),237-244","journal-title":"Int J Cardiol"},{"key":"ref=52","first-page":"CR232","volume":"16","author":"Wietlicka-Kokoszanek I.","year":"2010","unstructured":"Wietlicka-Kokoszanek I.; Jablecka A.; Smolarek I.; Bogdanski P.; Chmara E.; Korzeniowska K.; Kazmierczak M.; Kazmierczak E.; Musialik K.; Neopterin as a prognostic marker in patients with chronic heart failure. Med Sci Monit  2010,16(5),CR232-CR237","journal-title":"Med Sci Monit"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1093\/eurheartj\/ehi111","volume":"26","author":"Avanzas P.","year":"2005","unstructured":"Avanzas P.; Arroyo-Espliguero R.; Quiles J.; Roy D.; Kaski J.C.; Elevated serum neopterin predicts future adverse cardiac events in patients with chronic stable angina pectoris. Eur Heart J  2005,26(5),457-463","journal-title":"Eur Heart J"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1093\/icvts\/ivv219","volume":"21","author":"Berg K.S.","year":"2015","unstructured":"Berg K.S.; Stenseth R.; Pleym H.; Wahba A.; Videm V.; Neopterin predicts cardiac dysfunction following cardiac surgery. Interact Cardiovasc Thorac Surg  2015,21(5),598-603","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1134\/S1990750807040142","volume":"1","author":"Bershova T.V.","year":"2007","unstructured":"Bershova T.V.; Shmatkova Y.V.; Ivanov A.P.; Bakanov M.I.; Basargina E.N.; Zurabova R.B.; Monaenkova S.V.; Gerasimova Y.V.; Biochemical and immunological markers of insufficiency of blood circulation in children with cardiomyopathies. Biochem Suppl Ser B: Biomed Chem  2007,1(4),370-376","journal-title":"Biochem Suppl Ser B: Biomed Chem"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S0167-5273(99)00118-7","volume":"72","author":"Brunkhorst F.M.","year":"1999","unstructured":"Brunkhorst F.M.; Clark A.L.; Forycki Z.F.; Anker S.D.; Pyrexia, procalcitonin, immune activation and survival in cardiogenic shock: The potential importance of bacterial translocation. Int J Cardiol  1999,72(1),3-10","journal-title":"Int J Cardiol"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/S1388-9842(00)00148-3","volume":"3","author":"Caforio A.L.P.","year":"2001","unstructured":"Caforio A.L.P.; Goldman J.H.; Baig M.K.; Mahon N.J.; Haven A.J.; Souberbielle B.E.; Holt D.W.; Dalgleish A.G.; McKenna W.J.; Elevated serum levels of soluble interleukin-2 receptor, neopterin and \u03b2-2-microglobulin in idiopathic dilated cardiomyopathy: Relation to disease severity and autoimmune pathogenesis. Eur J Heart Fail  2001,3(2),155-163","journal-title":"Eur J Heart Fail"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.clinbiochem.2012.10.022","volume":"46","author":"Caruso R.","year":"2013","unstructured":"Caruso R.; De Chiara B.; Campolo J.; Verde A.; Musca F.; Belli O.; Parolini M.; Cozzi L.; Moreo A.; Frigerio M.; Parodi O.; Neopterin levels are independently associated with cardiac remodeling in patients with chronic heart failure. Clin Biochem  2013,46(1-2),94-98","journal-title":"Clin Biochem"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.cyto.2012.04.018","volume":"59","author":"Caruso R.","year":"2012","unstructured":"Caruso R.; Verde A.; Campolo J.; Milazzo F.; Russo C.; Boroni C.; Parolini M.; Trunfio S.; Paino R.; Martinelli L.; Frigerio M.; Parodi O.; Severity of oxidative stress and inflammatory activation in end-stage heart failure patients are unaltered after 1 month of left ventricular mechanical assistance. Cytokine  2012,59(1),138-144","journal-title":"Cytokine"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/j.atherosclerosis.2009.04.032","volume":"207","author":"Est\u00e9vez-Loureiro R.","year":"2009","unstructured":"Est\u00e9vez-Loureiro R.; Recio-Mayoral A.; Sieira-Rodr\u00edguez-Moret J.A.; Trallero-Aragu\u00e1s E.; Kaski J.C.; Neopterin levels and left ventricular dysfunction in patients with chronic stable angina pectoris. Atherosclerosis  2009,207(2),514-518","journal-title":"Atherosclerosis"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1515\/cclm.1993.31.3.111","volume":"31","author":"Fuchs D.","year":"1993","unstructured":"Fuchs D.; Samsonov M.; Tilz G.P.; Reibnegger G.; Belenkov J.N.; Nassonov E.L.; Wachter H.; Stimulated cellular immune system in patients with congestive heart failure. Clin Chem Lab Med  1993,31(3),111-114","journal-title":"Clin Chem Lab Med"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s11748-010-0669-9","volume":"59","author":"Hennig F.","year":"2011","unstructured":"Hennig F.; Stepanenko A.V.; Lehmkuhl H.B.; Kukucka M.; Dandel M.; Krabatsch T.; Hetzer R.; Potapov E.V.; Neurohumoral and inflammatory markers for prediction of right ventricular failure after implantation of a left ventricular assist device. Gen Thorac Cardiovasc Surg  2011,59(1),19-24","journal-title":"Gen Thorac Cardiovasc Surg"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"2230","DOI":"10.3390\/jcm8122230","volume":"8","author":"Lanser L.","year":"2019","unstructured":"Lanser L.; P\u00f6lzl G.; Fuchs D.; Weiss G.; Kurz K.; Neopterin is associated with disease severity and outcome in patients with non-ischaemic heart failure. J Clin Med  2019,8(12),2230","journal-title":"J Clin Med"},{"key":"ref=64","first-page":"778","volume":"118","author":"Mjelva \u00d8.R.","year":"2018","unstructured":"Mjelva \u00d8.R.; Svingen G.F.T.; Pedersen E.K.R.; Seifert R.; Kval\u00f8y J.T.; Midttun \u00d8.; Ueland P.M.; Nordrehaug J.E.; Nyg\u00e5rd O.; Nilsen D.W.T.; Fibrinogen and neopterin is associated with future myocardial infarction and total mortality in patients with stable coronary artery disease. Thromb Haemost  2018,118(4),778-790","journal-title":"Thromb Haemost"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1093\/eurheartj\/ehr032","volume":"32","author":"Nazer B.","year":"2011","unstructured":"Nazer B.; Ray K.K.; Sloan S.; Scirica B.; Morrow D.A.; Cannon C.P.; Braunwald E.; Prognostic utility of neopterin and risk of heart failure hospitalization after an acute coronary syndrome. Eur Heart J  2011,32(11),1390-1397","journal-title":"Eur Heart J"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1046\/j.1365-2796.1998.00240.x","volume":"243","author":"Samsonov M.","year":"1998","unstructured":"Samsonov M.; Lopatin J.; Tilz G.P.; Artner-Dworzak E.; Nassonov E.; Mareev V.; Belenkov J.; Wachter H.; Fuchs D.; The activated immune system and the renin-angiotensin-aldosterone system in congestive heart failure. J Intern Med  1998,243(2),93-98","journal-title":"J Intern Med"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.1016\/j.amjcard.2014.03.016","volume":"113","author":"Shao Z.","year":"2014","unstructured":"Shao Z.; Zhang R.; Shrestha K.; Borowski A.G.; Schuster A.; Thakur A.; Hazen S.L.; Tang W.H.W.; Usefulness of elevated urine neopterin levels in assessing cardiac dysfunction and exercise ventilation inefficiency in patients with chronic systolic heart failure. Am J Cardiol  2014,113(11),1839-1843","journal-title":"Am J Cardiol"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2014\/585067","volume":"2014","author":"Wojciechowska C.","year":"2014","unstructured":"Wojciechowska C.; Wodniecki J.; Wojnicz R.; Romuk E.; Jache\u0107 W.; Tomasik A.; Skrzep-Poloczek B.; Spinczyk B.; Nowalany-Kozielska E.; Neopterin and beta-2 microglobulin relations to immunity and inflammatory status in nonischemic dilated cardiomyopathy patients. Mediators Inflamm  2014,2014,1-8","journal-title":"Mediators Inflamm"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1007\/s00228-022-03290-6","volume":"78","author":"Dogheim G.M.","year":"2022","unstructured":"Dogheim G.M.; Khairat I.; Omran G.A.; El-Haggar S.M.; Amrawy A.M.E.; Werida R.H.; Clinical comparative study assessing the effect of ivabradine on neopterin and NT-Pro BNP against standard treatment in chronic heart failure patients. Eur J Clin Pharmacol  2022,78(6),943-954","journal-title":"Eur J Clin Pharmacol"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1177\/0003319706290743","volume":"57","author":"Barani J.","year":"2006","unstructured":"Barani J.; Mattiasson I.; Lindblad B.; Gotts\u00e4ter A.; Cardiac function, inflammatory mediators and mortality in critical limb ischemia. Angiology  2006,57(4),437-444","journal-title":"Angiology"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1093\/clinchem\/38.5.678","volume":"38","author":"Samsonov M.","year":"1992","unstructured":"Samsonov M.; Fuchs D.; Reibnegger G.; Belenkov J.N.; Nassonov E.L.; Wachter H.; Patterns of serological markers for cellular immune activation in patients with dilated cardiomyopathy and chronic myocarditis. Clin Chem  1992,38(5),678-680","journal-title":"Clin Chem"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1093\/gerona\/glq066","volume":"65A","author":"Spencer M.E.","year":"2010","unstructured":"Spencer M.E.; Jain A.; Matteini A.; Beamer B.A.; Wang N.Y.; Leng S.X.; Punjabi N.M.; Walston J.D.; Fedarko N.S.; Serum levels of the immune activation marker neopterin change with age and gender and are modified by race, BMI, and percentage of body fat. J Gerontol A Biol Sci Med Sci  2010,65A(8),858-865","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"465","DOI":"10.2478\/jomb-2018-0004","volume":"37","author":"\u00dcn\u00fcvar S.","year":"2018","unstructured":"\u00dcn\u00fcvar S.; Tanr\u0131verdi Z.; Aslanhan H.; Potential prognostic role of immune system activation marker neopterin in patients with type 2 diabetes. J Med Biochem  2018,37(4),465-469","journal-title":"J Med Biochem"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1093\/clinchem\/48.4.643","volume":"48","author":"Schennach H.","year":"2002","unstructured":"Schennach H.; Murr C.; G\u00e4chter E.; Mayersbach P.; Sch\u00f6nitzer D.; Fuchs D.; Factors influencing serum neopterin concentrations in a population of blood donors. Clin Chem  2002,48(4),643-645","journal-title":"Clin Chem"},{"key":"ref=75","first-page":"47","volume":"18","author":"Polyakova E.A.","year":"2021","unstructured":"Polyakova E.A.; Mikhaylov E.N.; Sonin D.L.; Cheburkin Y.V.; Galagudza M.M.; Neurohumoral, cardiac and inflammatory markers in the evaluation of heart failure severity and progression. J Geriatr Cardiol  2021,18(1),47-66","journal-title":"J Geriatr Cardiol"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.3390\/jcm12041641","volume":"12","author":"Nechita V.I.","year":"2023","unstructured":"Nechita V.I.; Hajjar N.A.; Drugan C.; C\u0103tan\u0103 C.S.; Moi\u015f E.; Nechita M.A.; Graur F.; Chitotriosidase and neopterin as potential biomarkers for the evaluation of complicated cholecystitis-A pilot study. J Clin Med  2023,12(4),1641","journal-title":"J Clin Med"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"3033","DOI":"10.3390\/diagnostics12123033","volume":"12","author":"Hojda S.E.","year":"2022","unstructured":"Hojda S.E.; Chis I.C.; Clichici S.; Biomarkers in pulmonary arterial hypertension. Diagnostics  2022,12(12),3033","journal-title":"Diagnostics"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"109147","DOI":"10.1016\/j.intimp.2022.109147","volume":"111","author":"Saghazadeh A.","year":"2022","unstructured":"Saghazadeh A.; Rezaei N.; Elevated neopterin in tuberculosis and co-infection with HIV and the effect of treatment: A systematic review, meta-analysis, and meta-regression. Int Immunopharmacol  2022,111,109147","journal-title":"Int Immunopharmacol"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"e104255","DOI":"10.1371\/journal.pone.0104255","volume":"9","author":"Li C.","year":"2014","unstructured":"Li C.; Wang Y.; Qiu Q.; Shi T.; Wu Y.; Han J.; Chai X.; Wang W.; Qishenyiqi protects ligation-induced left ventricular remodeling by attenuating inflammation and fibrosis via STAT3 and NF-\u03baB signaling pathway. PLoS One  2014,9(8),e104255","journal-title":"PLoS One"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cardfail.2006.09.008","volume":"13","author":"Krum H.","year":"2007","unstructured":"Krum H.; Ashton E.; Reid C.; Kalff V.; Rogers J.; Amarena J.; Singh B.; Tonkin A.; Double-blind, randomized, placebo-controlled study of high-dose HMG CoA reductase inhibitor therapy on ventricular remodeling, pro-inflammatory cytokines and neurohormonal parameters in patients with chronic systolic heart failure. J Card Fail  2007,13(1),1-7","journal-title":"J Card Fail"}],"container-title":["Current Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0109298673258661231003045907","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/222066\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0109298673258661231003045907","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T07:19:02Z","timestamp":1743146342000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/222066\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":80,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0109298673258661231003045907","relation":{},"ISSN":["0929-8673"],"issn-type":[{"type":"print","value":"0929-8673"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2023-04-19","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-08-10","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-08-18","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-02-27","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}